Navigation Links
CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain

its proprietary synDNA(TM) production and ssDNA expression technology. The company has developed a breakthrough synthetic process for large-scale production of biologically active DNA that can be made faster and cleaner than production using traditional fermentation methods and has developed a novel expression vector that enables production of therapeutic DNA inside the cell. CytoGenix currently holds 11 granted patents and about 49 international or US pending patent applications claiming methods and materials in connection with these platform technologies.

SAFE HARBOR: Except for statements of historical fact, the statements in this press release are forward-looking. Such statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include, but are not limited to, general economic conditions, risks associated with the acceptance of new products, competition, and other factors more fully detailed in the company's filings with the Securities and Exchange Commission. Additional information about CytoGenix and its technology can be found on the website at www.cytogenix.com.

Contact

CytoGenix, Inc., Houston
Media Contact:
Pam Schertz, 713-789-0070


'"/>




Page: 1 2

Related medicine technology :

1. CytoGenix Announces Successful Testing of synDNA Vaccine for Avian Influenza Virus
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:7/24/2008)...., July 24 /- Ortho-McNeil Neurologic...als, Inc., announced today,that the U.S. Food and ...clusivity for TOPAMAX(R) (topiramate), based on st...y the FDA to investigate the use of TOPAMAX,in ped...nset seizures., In addition to granting pediatric...
(Date:7/24/2008)...Calif., July 24 /- Alexza,P...day that it has initiated,its second Phase 3 clini...04 is an inhalation product candidate being develo...ts with schizophrenia or bipolar disorder.,Alexza ...pharmacokinetic,(PK) properties resulting from inh...
(Date:7/24/2008)...y 24 /PRNewswire-USNewswire/ -- Headlines claiming...whole story. The small scale,preliminary study th...eproduction, is based on recollected intake of soy...s. "This study is confounded by many,issues, thus ...eal of,caution," warned Dr. Tammy Hedlund, a resea...
(Date:7/24/2008)...hermometer designed to take body temperature, for ...ewswire-FirstCall/ --- Kidz-Med, Inc.,(subsidiary ... ASFX),United States distributor of the Thermofoc...o announce the results of a clinical study,conduct...ty of Milan, in,Milan, Italy, which proves that th...
Breaking Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6Soyfoods Do Not Impact Sperm Count 2Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Human embryonic stem cell lines created that avoid immune rejection 8621 1Human embryonic stem cell lines created that avoid immune rejection 8621 2Make Safe Toys Your Holiday Priority 8619 1Make Safe Toys Your Holiday Priority 8619 2Make Safe Toys Your Holiday Priority 8619 3Fisheries should be regarded as a part of the maritime environment 1689 1Fisheries should be regarded as a part of the maritime environment 1689 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 1It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 1687 3
...f.--(BUSINESS WIRE)--Jun 4, 2007 - Researchers at ...luminated the path,taken by human neural stem cell...nd mice, and found that the cells successfully,nav...h group placed miniscule particles of iron inside,...magnetic,resonance imaging. With the ability to mo...
... Affiliated Physicians Participate in ASCO,Proceed...ding cancer,researcher affiliated with the US Onco...ndomized, multicenter phase III trial,that compare...o,regimens of adjuvant therapy for patients with h...iven in an oral presentation by Dr.,David Loesch o...
Other Medicine Technology:Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 2Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 3Stanford Researchers Track Human Stem Cells Transplanted Into Rat,Brain 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5
(Date:7/25/2008)...CESS, N.Y., July 25 /PRNewswire-USNewswire/ -- Ant...f Quality Officer and Vice President,of Strategic ...th Fund, a,national foundation committed to improv...ted the foundation,s Program on Health Care Qualit....newscom.com/cgi-bin/prnh/20080725/DC28791LOGO ),...
(Date:7/25/2008)...ON, Calif., July 25 /PRNewswire-FirstCall/ -- Thor...n device-based mechanical,circulatory support ther...,today announced that it will report its operating...hs of fiscal 2008 on Thursday, July 31., The comp...ancial,results and operating activities to all int...
(Date:7/25/2008)...A July 24, 2008 Being overweight or obese is not...ut is also a public health issue that impacts othe...ealth Services Research reveals that the extra Me...ple could place a significant financial burden on ...dollars across the entire current Medicare populat...
(Date:7/25/2008)...July 25 /PRNewswire/ -- BeaconEquity.com announces... news today., Investors can view all of the daily...nEquity.com/m , Today,s Trade Alerts include: DUS...ok Pharmaceuticals Inc. (Nasdaq: MBRK ), NovaMed ..., Affymetrix Inc. (Nasdaq: AFFX ) and,Abaxis Inc....
Breaking Medicine News(10 mins):Health News:IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead 2Health News:Thoratec Schedules Second Quarter 2008 Conference Call, Webcast 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3
...n have Complication as its other name. Among the m...dreaded would be the foot ulcer, as damage can be ... with this dreaded foot ulcer, a boon in disguise ...gh voltage electric current to the skin. //Such an...
...s can also repair damaged ankles claim the researc...ing knee injuries, but it is also a valuable metho...sive surgical technique it is being applied in new... relieve different ankle problems, including ligam...
...ped on a daily basis. One of these latest laser te...ering from a degenerative eye condition. This dege...erneath the retina and leak fluid, causing scarrin...ve come up with a new therapy called the Photodyna...
... reducer Paracetamol, whose active ingredient is A...f the stroke. The fever-reducer acetaminophen lowe...e, according to a new study conducted in The Nethe...ing the first few days, though small enough that t...
Other Medicine News:Health News:Arthroscopy for Ankles 2
Eftiar® offers the vitreoretinal surgeon a temporary tamponade for efficient re-attachment of the retina, release of subretinal fluid, dissection of fibro-vascular proliferation and controlling r
ROB-NEL Catheters (100% Latex-Free)
Red Rubber Robinson Catheters (Latex)
Urethral Red Rubber Catheters (Latex)
Medicine Products: